Hsiao, Sheng-Mou <br/><br/>
Treatment Outcome of Overactive Bladder Patients Receiving Antimuscarinic Therapy for More than One Year.  [electronic resource] 

 -  Lower urinary tract symptoms  Jan 2018 
 - 21-26 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1757-5672 
<br/><br/><label>Standard No.: </label>10.1111/luts.12136  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Constipation--chemically induced<br/>Female<br/>Humans<br/>Male<br/>Mandelic Acids--adverse effects<br/>Middle Aged<br/>Muscarinic Antagonists--adverse effects<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Solifenacin Succinate--adverse effects<br/>Time Factors<br/>Tolterodine Tartrate--adverse effects<br/>Treatment Outcome<br/>Urinary Bladder, Overactive--drug therapy<br/>Urodynamics<br/>Vision Disorders--chemically induced<br/>Xerostomia--chemically induced<br/>Young Adult